Cleared Traditional

K971269 - DSL ACTIVE T4 EIA
(FDA 510(k) Clearance)

May 1997
Decision
48d
Days
Class 2
Risk

K971269 is an FDA 510(k) clearance for the DSL ACTIVE T4 EIA. This device is classified as a Enzyme Immunoassay, Non-radiolabeled, Total Thyroxine (Class II - Special Controls, product code KLI).

Submitted by Diagnostic Systems Laboratories, Inc. (Webster, US). The FDA issued a Cleared decision on May 22, 1997, 48 days after receiving the submission on April 4, 1997.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1700.

Submission Details

510(k) Number K971269 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 04, 1997
Decision Date May 22, 1997
Days to Decision 48 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code KLI — Enzyme Immunoassay, Non-radiolabeled, Total Thyroxine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1700

Similar Devices — KLI Enzyme Immunoassay, Non-radiolabeled, Total Thyroxine

All 85
VITROS? Automation Solutions
K160495 · Ortho-Clinical Diagnostics, Inc. · Oct 2016
ACE -GT REAGENT; ACE LIPASE RAGENT; ACE T4 REAGENT
K131515 · Alfa Wassermann · Aug 2013
GSP NEONATAL THYROXINE (T4)
K103484 · Wallac Oy, A Subsidiary of Perkinelmer, Inc. · Apr 2011
ADVIA CENTAUR SYSTEM WITH STREAMLAB ANALYTICAL WORKCELL
K082638 · Siemens Healthcare Diagnostics, Inc. · Feb 2009
ACCUBIND NEONATAL T4 MICROPLATE EIA, MODEL 2625-300
K030860 · Monobind · Aug 2003
ACCESS TOTAL T4 ASSAY
K023369 · Beckman Coulter, Inc. · Dec 2002